Does Liposomal Glutathione Work? The One Trial and the Formats
In this article
- What does "liposomal" mean on a glutathione label?
- Does oral glutathione get absorbed at all?
- What did the liposomal glutathione trial find?
- Has liposomal glutathione been compared with ordinary glutathione?
- What about S-acetyl glutathione?
- How do you read a glutathione label?
- Does liposomal glutathione have different side effects?
- What we don't know
- Frequently asked questions
Liposomal glutathione has one human trial behind it: in 12 healthy adults taking 500 or 1,000 mg a day for four weeks, with no placebo group and funding from a liposomal-glutathione maker, whole-blood glutathione was up to 40% higher by two weeks. That trial measured blood levels, not how anyone felt or looked.1 Swallowed glutathione has a supplier-funded four-week placebo-controlled trial in 40 adults in which red-cell glutathione and two oxidative-stress markers did not change, and a six-month one in 54 adults in which glutathione in red cells, plasma and lymphocytes rose 30 to 35% at 1,000 mg a day and 17 to 29% in blood and red cells at 250 mg, returning to baseline a month after stopping.2, 3 No trial has compared the formats on any outcome beyond blood levels, so none can be called better than another. Glutathione has no authorised health claim in the UK; what follows is what the trials measured.4 Part of the Wellgard guide what does glutathione do in the body.
Sources checked on 1 November 2026.
What does "liposomal" mean on a glutathione label?
A liposome is a microscopic sphere of phospholipid, the kind of fat molecule that forms cell membranes, with the glutathione carried inside it or within its layers. The idea is to carry more of the molecule past the gut enzyme, gamma-glutamyltransferase, that breaks part of a swallowed dose into its three amino acids.5 The word on a label tells you the maker used that process, not the size of the liposomes, how much glutathione sits inside them or how the product behaved in anyone's body; no format has an authorised claim of its own.4
Does oral glutathione get absorbed at all?
Part of it, and the answer depends on what is measured and when. In seven volunteers given a single 3 g dose in 1992, free glutathione in plasma did not rise over four and a half hours; this is the study the "does not absorb" line comes from.5 A 2014 study found glutathione bound to plasma proteins rising 60 to 120 minutes after a dose while the free fraction did not, one explanation for that early result.6 The four-week and six-month trials in the opening give the longer answer: a single dose read in plasma shows little; daily dosing read in cells over months shows a rise that lasts as long as the supplement does.2, 3
What did the liposomal glutathione trial find?
The 2018 pilot gave 12 healthy adults 500 or 1,000 mg of liposomal glutathione a day for one month and took blood at baseline and after one, two and four weeks.1 Glutathione was higher after one week, with the largest rises at two: 40% in whole blood, 25% in red cells, 28% in plasma and 100% in peripheral blood mononuclear cells. Plasma 8-isoprostane, an oxidative-stress marker, fell 35%, the oxidised-to-reduced ratio fell 20%, natural-killer cell cytotoxicity rose by up to 400% and lymphocyte proliferation by up to 60%.1 Three facts sit beside those numbers. There was no placebo group, so every change is against each person's own baseline. There were 12 people; the authors write there were "no differences observed between dose groups, but statistical power was limited due to the small sample size". And the study was funded by a company that sells liposomal glutathione; the authors call their findings preliminary.1 That is the published answer to "what are the benefits of liposomal glutathione": blood markers in a dozen people over a month, nothing about skin, energy or how people felt, and none of it is an authorised claim.4
Has liposomal glutathione been compared with ordinary glutathione?
Once, after a single dose, never on an outcome: a 2026 open-label study by a supplement company's own scientists, six people per arm, reported a peak plasma glutathione about six times higher from its liposomal product than from plain glutathione after one 1 g dose.7 It has not been repeated; the other format studies had no liposomal arm.
| Study | People | Form and daily dose (mg or g) | Length (hours, weeks or months) | Control | Funding | What was found |
|---|---|---|---|---|---|---|
| Allen and Bradley 20112 | 40 healthy adults | Swallowed, 1,000 mg | 4 weeks | Placebo, double-blind | Supplier-funded | Red-cell glutathione and two urinary markers unchanged |
| Richie 20153 | 54 non-smoking adults | Swallowed, 250 or 1,000 mg | 6 months, then 1 month off | Placebo, double-blind | Not stated in the abstract | Up 30 to 35% at 1,000 mg, 17 to 29% at 250 mg; baseline after a month off |
| Sinha 20181 | 12 healthy adults | Liposomal, 500 or 1,000 mg | 4 weeks | None | Liposomal-glutathione maker | Whole blood up to 40%, white cells up to 100% at 2 weeks |
| Prasad 20267 | 12 healthy adults, 6 per arm | Liposomal or plain, one 1 g dose | 24 hours | Plain glutathione, open-label | All authors employed by a supplement company | Peak plasma level about 6 times higher with liposomal |
| Schmitt 20158 | 20 adults with metabolic syndrome | Sublingual or swallowed glutathione, 450 mg; or NAC, 200 mg | 3 weeks each, crossover | Each against the others | Sponsored by the maker; two of four authors employed there | Plasma glutathione and reduced-to-oxidised ratio higher in the sublingual period |
| Jung 20269 | Not in the abstract | Dissolving film or tablet: one 300 mg dose, then 100 mg | Single dose; 4 weeks | Tablet | Company co-authors | Film higher in plasma at 4 and 6 hours; both raised glutathione over 4 weeks |
| Bruggeman 201910 | 15 healthy adults | 200 mg held in the mouth 90 seconds | 2 hours | Placebo, crossover, single-blind | Sponsor-funded | Red-cell glutathione higher than placebo within 2 hours |
Every study in the table except the four-week swallowed trial reported higher blood glutathione; the studies differ in size, length, control and funder, and none measured a clinical outcome. No trial has set two formats against each other for long enough, in enough people, with a placebo, to show that one does more for a person than another, so "liposomal vs reduced glutathione" has no evidence-based winner.
What about S-acetyl glutathione?
S-acetyl glutathione is glutathione with an acetyl group attached. In an opinion published in September 2026, the European Food Safety Authority concluded it is safe at 300 mg a day for adults, excluding pregnant and breastfeeding women and children under 10, noting that human trials of ordinary oral glutathione support its safety in adults.11 It is a safety assessment of a different form, not an efficacy finding; no trial has compared the forms.
How do you read a glutathione label?
Three things. The form: reduced L-glutathione or the acetylated form; "liposomal" describes the carrier, not a different ingredient. The milligrams per capsule or per daily serving, not per bottle. And that daily figure set against the trial doses as facts: 100 mg a day raised circulating glutathione over four weeks as a film or a tablet;9 1,000 mg a day for four weeks left red-cell glutathione unchanged, while 250 mg a day raised blood and red-cell glutathione 17 to 29% over six months;2, 3 and 500 to 1,000 mg a day was the liposomal pilot's range.1 For timing and food, see how to take glutathione.
Does liposomal glutathione have different side effects?
Nothing in the record says so. The liposomal pilot reported no serious adverse effects and attributed no minor event to either dose, and the six-month trial reported no serious adverse events;1, 11 the film-and-tablet study reported no adverse events over four weeks.9 No trial has included pregnant or breastfeeding women, the one placebo-controlled children's trial was in cystic fibrosis under medical supervision, and EFSA excluded pregnant and breastfeeding women and under-10s for the acetylated form, so anyone pregnant, breastfeeding or buying for a child asks a GP, midwife or pharmacist first.11 The full list of cautions is on glutathione side effects.
What we don't know
- Whether the liposomal form raises stores more than plain capsules over weeks of use: the only comparison was one dose in 12 people.7
- Whether any format changes how people feel or look: no format study measured it.1, 9, 10
- Anything past six months: the longest daily trial, of plain capsules, stopped there.3
Frequently asked questions
What is the most powerful form of glutathione?
No trial can tell you: each format has one study of its own, and the only head-to-head between liposomal and plain glutathione was a single dose in six people per arm, run by a supplement company.7 The building blocks, glycine, N-acetylcysteine and whey protein's cysteine, are a separate route with their own trials, set out on NAC vs glutathione and summarised in the glutathione hub; the EU assessors refused the NAC and whey claims that mentioned glutathione.4
Can I take liposomal glutathione every day, and for how long?
The liposomal pilot ran four weeks of daily dosing. Of the swallowed-glutathione trials, the four-week one at 1,000 mg a day found no change in blood glutathione, and the six-month one, the longest, found a rise that returned to baseline within a month of stopping.1, 2, 3 Nothing is known beyond six months; keep to the label's daily amount.
How quickly does liposomal glutathione work, and how can I tell?
In the 12-person pilot, which had no placebo group, blood glutathione was higher at one week and highest at two.1 Those are laboratory measurements: no liposomal trial has reported a change people could feel or see, there is no routine NHS test for "low glutathione", and no liposomal trial has measured skin or energy.
Who should not use liposomal glutathione, and what should I not mix it with?
No interactions are reported in the trial abstracts. No trial has included pregnant or breastfeeding women, and the one placebo-controlled children's trial was in cystic fibrosis; anyone in those groups, anyone with liver or kidney disease, and anyone on a prescribed medicine asks a pharmacist or GP first.11 Can I take collagen and glutathione together covers the pairing readers ask about most.
What is the best time to take liposomal glutathione?
No trial has compared morning with evening, or with and without food; the pilot's report gives no time of day, and the two-hour mouth-held study dosed people after an overnight fast.1, 10 Follow the label.
Sources
- Sinha R, et al. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. European Journal of Clinical Nutrition, 2018. Uncontrolled pilot, 12 healthy adults, four weeks; funded by a liposomal-glutathione company, with NIH support. PubMed 28853742.
- Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. Journal of Alternative and Complementary Medicine, 2011. Randomised double-blind placebo-controlled trial, 40 healthy adults, four weeks; funded by the glutathione supplier. PubMed 21875351.
- Richie JP Jr, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition, 2015. Randomised double-blind placebo-controlled trial, 54 adults completed, six months; funder not stated in the abstract. PubMed 24791752.
- Great Britain nutrition and health claims register, last updated 19 May 2026. gov.uk.
- Witschi A, et al. The systemic availability of oral glutathione. European Journal of Clinical Pharmacology, 1992. Single-dose study, 7 healthy volunteers. PubMed 1362956.
- Park EY, et al. Increase in the protein-bound form of glutathione in human blood after the oral administration of glutathione. Journal of Agricultural and Food Chemistry, 2014. Single-dose study in healthy volunteers. PubMed 24877771.
- Prasad KN, et al. Liposomal glutathione outperforms plain glutathione in uptake, cell regeneration and systemic availability. British Journal of Nutrition, 2026. Open-label single-dose study, 12 healthy adults, plus cell work; all authors employed by a supplement company. PubMed 41559937.
- Schmitt B, et al. Effects of N-acetylcysteine, oral glutathione and a novel sublingual form of GSH on oxidative stress markers. Redox Biology, 2015. Randomised crossover trial, 20 adults with metabolic syndrome, three weeks per period; sponsored by the sublingual product's maker. PubMed 26262996.
- Jung ES, et al. Formulation-dependent differences in systemic glutathione availability: orally dissolving film and tablet. European Journal of Pharmaceutics and Biopharmaceutics, 2026. Randomised open-label crossover (single dose) and four-week comparison; three of eight authors from two companies. PubMed 42392376.
- Bruggeman BK, et al. The absorptive effects of orobuccal non-liposomal nano-sized glutathione on blood glutathione parameters. PLoS One, 2019. Randomised single-blind placebo-controlled crossover, 15 healthy adults, single dose; funded by the product's company. PubMed 31039164.
- EFSA NDA Panel. Safety of S-acetyl glutathione pursuant to Regulation (EU) 2015/2283. EFSA Journal, 2026. Scientific opinion, adopted 2 July 2026. PubMed 42683004.
Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.
This article is general information, not medical advice.